Statistics for Vera Therapeutics, (id:6650 VERA)
Valuation metrics
Market cap
3.10B
Enterprise value
2.80B
Trailing P/E (ttm)
-21.09
Forward P/E
-15.76
PEG ratio
-15.76
Price/Sales (ttm)
Price/Book (mrq)
9.33
Enterprise Value/Revenue
Enterprise Value/EBITDA
-30.43
Overview
Shares outstanding
63.32M
Float
51.51M
Shares short
6.39M
% Held by insiders
0.07%
% Held by institutions
0.96%
Average volume (10 days)
952.78K
Average volume (90 days)
Price summary
52-Week low
13.01
52-Week high
51.61
52-Week change
71.87%
Beta
1.02
50-Day moving average
42.17
200-Day moving average
40.40
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-33.37%
Return on equity
-65.11%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-134,378,000.00
Diluted EPS (ttm)
-2.59
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
353.31M
Total cash per share (mrq)
5.58
Total debt (mrq)
54.91M
Total Debt/Equity (mrq)
19.00
Current ratio (mrq)
1.38K%
Book value per share (mrq)
5.25
Cash flow
Cash flow statement
-120,641,000.00
Levered free cash flow (LFCF)
-78,348,376.00